Literature DB >> 12767395

High-yield synthesis of the terminal 188Re triple bond N multiple bond from generator-produced [188ReO4](-).

Alessandra Boschi1, Cristina Bolzati, Licia Uccelli, Adriano Duatti.   

Abstract

A novel procedure for the high-yield preparation of Re-188 radiopharmaceuticals containing a terminal Re identical with N multiple bond is described. This method involves the reaction of [(188)Re][ReO(4)](-) with N-methyl S-methyl dithiocarbazate (DTCZ), as donor of nitrido nitrogen atoms, sodium oxalate and SnCl(2) to afford a mixture of two intermediate compounds. When this mixture is reacted with the sodium salt of a dithiocarbamate ligand (L) of the type Na[R(2)N-C(=S)S] (R = CH(3), CH(3)CH(2), CH(3)CH(2)CH(2)), the formation of the bis-substituted, neutral complexes [(188)Re][Re(N)(L)(2)] is easily obtained in high yield (> 95%). The complexes [(188)Re][Re(N)(L)(2)] were characterized by chromatographic methods, and by comparison with the corresponding complexes prepared at macroscopic level starting from a non-radioactive rhenium precursor. Biodistribution studies were carried out in rats. Results showed that the complexes [(188)Re][Re(N)(L)(2)] exhibited the same biological behavior of the analogous Tc-99m complexes reported previously. The easy application of the new synthetic procedure indicates that it could be conveniently employed for preparing a large class of new Re-188 complexes having potential utilization in nuclear medicine as therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767395     DOI: 10.1016/s0969-8051(03)00002-7

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  8 in total

1.  Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.

Authors:  Sibaprasad Bhattacharyya; Manish Dixit
Journal:  Dalton Trans       Date:  2011-05-03       Impact factor: 4.390

Review 2.  Dithiocarbamate complexes as radiopharmaceuticals for medical imaging.

Authors:  David J Berry; Rafael Torres Martin de Rosales; Putthiporn Charoenphun; Philip J Blower
Journal:  Mini Rev Med Chem       Date:  2012-10       Impact factor: 3.862

3.  N'-[Bis(benzyl-sulfan-yl)methyl-idene]-4-meth-oxy-benzohydrazide.

Authors:  Jerry P Jasinski; Ray J Butcher; S K Kushawaha; M K Bharty; N K Singh
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-03

Review 4.  Bifunctional chelators for radiorhenium: past, present and future outlook.

Authors:  Diana R Melis; Andrew R Burgoyne; Maarten Ooms; Gilles Gasser
Journal:  RSC Med Chem       Date:  2022-01-14

5.  Technetium-99m and rhenium-188 complexes with one and two pendant bisphosphonate groups for imaging arterial calcification.

Authors:  Jayanta Kumar Bordoloi; David Berry; Irfan Ullah Khan; Kavitha Sunassee; Rafael Torres Martin de Rosales; Catherine Shanahan; Philip J Blower
Journal:  Dalton Trans       Date:  2015-03-21       Impact factor: 4.390

6.  (188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside.

Authors:  Nicolas Lepareur; Valérie Ardisson; Nicolas Noiret; Etienne Garin
Journal:  Int J Mol Imaging       Date:  2012-02-22

Review 7.  188Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy.

Authors:  Alessandra Boschi; Petra Martini; Licia Uccelli
Journal:  Pharmaceuticals (Basel)       Date:  2017-01-19

Review 8.  Rhenium Radioisotopes for Medicine, a Focus on Production and Applications.

Authors:  Licia Uccelli; Petra Martini; Luca Urso; Teresa Ghirardi; Lorenza Marvelli; Corrado Cittanti; Aldo Carnevale; Melchiore Giganti; Mirco Bartolomei; Alessandra Boschi
Journal:  Molecules       Date:  2022-08-18       Impact factor: 4.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.